Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Multi-level Antimicrobial Susceptibility Testing Resources (MASTER)

Hot Paper:

September 2004

  1. 2004. New antimicrobial agents approved by the U.S. Food and Drug Administration in 2003 and new indications for previously approved agents. Antimicrob Agents Chemother. 48:1438-1439.
  2. Albayrak, F., F. Cokca, B. Erdem, and A. D. Aysev. 2004. Predictive value of nalidixic acid resistance for detecting salmonellae with decreased ciprofloxacin susceptibility. Int J of Antimicrob Agents 23:332-336.
  3. Alhambra, A., J. L. Gomez-Garces, and J. I. Alos. 2004. Susceptibility of Streptococcus agalactiae isolates from blood and urine to 18 widely used and recently marketed antibiotics. Clin Microbiol Infect. 10:267-268.
  4. Black, J. A., K. S. Thomson, and J. D. D. Pitout. 2004. Use of beta-lactamase inhibitors in disk tests to detect plasmid-mediated AmpC beta-lactamases. J Clin Microbiol. 42:2203-2206.
  5. Burgess, D. S., and I. Hall, Ronald G. 2004. In vitro killing of parenteral beta-lactams against standard and high inocula of extended-spectrum beta-lactamase and non-ESBL producing Klebsiella pneumoniae. Diagn Microbiol Infect Dis. 49:41-46.
  6. Carpenter, C. F., and H. F. Chambers. 2004. Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens. Clin Infect Dis. 38:994-1000.
  7. Chapin, K. C., and M. C. Musgnug. 2004. Evaluation of penicillin binding protein 2a latex agglutination assay for identification of methicillin-resistant Staphylococcus aureus directly from blood cultures. J Clin Microbiol. 42:1283-1284.
  8. Charlebois, E. D., F. Perdreau-Remington, B. Kreiswirth, D. R. Bangsberg, D. Ciccarone, B. A. Diep, V. L. Ng, K. Chansky, B. Edlin, and H. F. Chambers. 2004. Origins of community strains of methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 39:47-54.
  9. Cockerill, F.R. III and T.F. Smith. 2004. Response of the clinical microbiology laboratory to emerging (new) and reemerging infectious diseases. J Clin Microbiol. 42:2359-2365
  10. Cornaglia, G., W. Hryniewicz, V. Jarlier, G. Kahlmeter, H. Mittermayer, L. Stratchounski, and F. Baquero. 2004. European recommendations for antimicrobial resistance surveillance. Clin Microbiol Infect. 10:498-498.
  11. Critchley, I. A., and J. A. Karlowsky. 2004. Optimal use of antibiotic resistance surveillance systems. Clin Microbiol Infect. 10:502-511.
  12. Dias, C. G., M. V. Ropke, S. Superti, L. Berquo, and P. d'Azevedo. 2004. Use of a novel selective medium to detect methicillin-resistant Staphylococcus aureus in colonized patients of an intensive care unit. Infect Control Hosp Epidemiol. 25:130-2.
  13. Diekema, D. J., Dodgson, K. J., Sigurdardottir, B. and M. A. Pfaller. 2004. Rapid detection of antimicrobial-resistant organism carriage: an unmet clinical need. J Clin Microbiol. 42:2879-2883.
  14. Diekema, D. J., K. Lee, P. Raney, L. A. Herwaldt, G. V. Doern, and F. C. Tenover. 2004. Accuracy and appropriateness of antimicrobial susceptibility test reporting for bacteria isolated from blood cultures. J Clin Microbiol. 42:2258-2260.
  15. Dodgson, K. J. 2004. VRE detection: A new gold standard? Clin Microbiol Newsletter. 26:25-30.
  16. Donay, J.-L., D. Mathieu, P. Fernandes, C. Pregermain, P. Bruel, A. Wargnier, I. Casin, F. X. Weill, P. H. Lagrange, and J. L. Herrmann. 2004. Evaluation of the automated Phoenix system for potential routine use in the clinical microbiology laboratory. J Clin Microbiol. 42:1542-1546.
  17. Ernst, E. J., D. J. Diekema, B. J. BootsMiller, T. Vaughn, J. W. Yankey, S. D. Flach, M. M. Ward, C. L. J. Franciscus, E. Acosta, M. A. Pfaller, and B. N. Doebbeling. 2004. Are United States hospitals following national guidelines for the analysis and presentation of cumulative antimicrobial susceptibility data? Diagn Microbiol Infect Dis. 49:141-145.
  18. Funke, G., and P. Funke-Kissling. 2004. Use of the BD PHOENIX automated microbiology system for direct identification and susceptibility testing of gram-negative rods from positive blood cultures in a three-phase trial. J Clin Microbiol. 42:1466-1470.
  19. Hacek, D. M., R. L. Cordell, G. A. Noskin, and L. R. Peterson. 2004. Computer-assisted surveillance for detecting clonal outbreaks of nosocomial infection. J Clin Microbiol. 42:1170-1175.
  20. Hasenbein, M. E., J. E. Warner, K. G. Lambert, S. E. Cole, A. B. Onderdonk, and A. J. McAdam. 2004. Detection of multiple macrolide- and lincosamide-resistant strains of Streptococcus pyogenes from patients in the Boston area. J Clin Microbiol. 42:1559-1563.
  21. Hecht, D. W. 2004. Prevalence of antibiotic resistance in anaerobic bacteria: worrisome developments. Clin Infect Dis. 39:92-7.
  22. Heelan, J. S., M. E. Hasenbein, and A. J. McAdam. 2004. Resistance of Group B Streptococcus to selected antibiotics including erythromycin and clindamycin. J Clin Microbiol. 42:1263-1264.
  23. Heginbothom, M. L., J. T. Magee, J. L. Bell, F. D. J. Dunstan, A. J. Howard, S. L. Hillier, S. R. Palmer, B. W. Mason, and on behalf of the Welsh Antibiotic Study Group. 2004. Laboratory testing policies and their effects on routine surveillance of community antimicrobial resistance. J Antimicrob Chemother. 53:1010-1017.
  24. Hooton, T. M., R. Besser, B. Foxman, T. R. Fritsche, and L. E. Nicolle. 2004. Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy. Clin Infect Dis. 39:75-80.
  25. Jorgensen, J. H., S. A. Crawford, M. L. McElmeel, and K. R. Fiebelkorn. 2004. Detection of inducible clindamycin resistance of staphylococci in conjunction with performance of automated broth susceptibility testing. J Clin Microbiol. 42:1800-1802.
  26. Kipp, F., K. Becker, G. Peters, and C. von Eiff. 2004. Evaluation of different methods to detect methicillin resistance in small-colony variants of Staphylococcus aureus. J Clin Microbiol. 42:1277-1279.
  27. Koeth, L. M., C. E. Good, P. C. Appelbaum, E. J. C. Goldstein, A. C. Rodloff, M. Claros, and L. J. Dubreuil. 2004. Surveillance of susceptibility patterns in 1297 European and US anaerobic and capnophilic isolates to co-amoxiclav and five other antimicrobial agents. J Antimicrob Chemother. 53:1039-1044.
  28. Lautenbach, E., B. L. Strom, I. Nachamkin, W. B. Bilker, A. M. Marr, L. A. Larosa, and N. O. Fishman. 2004. Longitudinal trends in fluoroquinolone resistance among Enterobacteriaceae isolates from inpatients and outpatients, 1989-2000: differences in the emergence and epidemiology of resistance across organisms. Clin Infect Dis. 38:655-62.
  29. Liu, C., and H. F. Chambers. 2003. Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods. Antimicrob Agents Chemother. 47:3040-5.
  30. Livermore, D. M., A. M. Sefton, and G. M. Scott. 2003. Properties and potential of ertapenem. J Antimicrob Chemother 52:331-44.
  31. Lyytikainen, O., M. Rautio, P. Carlson, V. J. Anttila, R. Vuento, H. Sarkkinen, A. Kostiala, M. L. Vaisanen, A. Kanervo, and P. Ruutu. 2004. Nosocomial bloodstream infections due to viridans streptococci in haematological and non-haematological patients: species distribution and antimicrobial resistance. J Antimicrob Chemother. 53:631-4.
  32. Magee, J. T., and on behalf of the Welsh Antibiotic Study Group. 2004. Effects of duplicate and screening isolates on surveillance of community and hospital antibiotic resistance. J Antimicrob Chemother. 54:155-162.
  33. Nicodemo, A. C., M. R. E. Araujo, A. S. Ruiz, and A. C. Gales. 2004. In vitro susceptibility of Stenotrophomonas maltophilia isolates: comparison of disc diffusion, Etest and agar dilution methods. J Antimicrob Chemother. 53:604-608.
  34. Ostrosky-Zeichner, L., J. H. Rex, P. G. Pappas, R. J. Hamill, R. A. Larsen, H. W. Horowitz, W. G. Powderly, N. Hyslop, C. A. Kauffman, J. Cleary, J. E. Mangino, and J. Lee. 2003. Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States. Antimicrob Agents Chemother. 47:3149-54.
  35. Paterson, D. L., W. C. Ko, A. Von Gottberg, S. Mohapatra, J. M. Casellas, H. Goossens, L. Mulazimoglu, G. Trenholme, K. P. Klugman, R. A. Bonomo, L. B. Rice, M. M. Wagener, J. G. McCormack, and V. L. Yu. 2004. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases. Clin Infect Dis. 39:31-7.
  36. Perez-Vazquez, M., F. Roman, B. Aracil, R. Canton, and J. Campos. 2004. Laboratory detection of Haemophilus influenzae with decreased susceptibility to nalidixic acid, ciprofloxacin, levofloxacin, and moxifloxacin due to gyrA and parC mutations. J Clin Microbiol. 42:1185-1191.
  37. Rosario-Rosado, R. V., A. A. Rene, and B. Jones. 2004. Descriptive analysis of patients with community-onset and hospital-onset methicillin-resistant Staphylococcus aureus infections. Infect Control Hosp Epidemiol. 25:171-3.
  38. Rupali, P., O. C. Abraham, M. V. Jesudason, T. J. John, A. Zachariah, S. Sivaram, and D. Mathai. 2004. Treatment failure in typhoid fever with ciprofloxacin susceptible Salmonella enterica Serotype Typhi. Diagn Microbiol Infect Dis. 49:1-3.
  39. Sakoulas, G., P. A. Moise-Broder, J. Schentag, A. Forrest, R. C. Moellering, Jr., and G. M. Eliopoulos. 2004. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol. 42:2398-2402.
  40. Schreckenberger, P. C., E. Ilendo, and K. L. Ristow. 2004. Incidence of constitutive and inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci in a community and a tertiary care hospital. J Clin Microbiol. 42:2777-2779.
  41. Shopsin, B., X. Zhao, B. N. Kreiswirth, G. S. Tillotson, and K. Drlica. 2004. Are the new quinolones appropriate treatment for community-acquired methicillin-resistant Staphylococcus aureus? Int J Antimicrob Agents. 24:32-34.
  42. Tambyah, P., J. Marx, and D. Maki. 2004. Nosocomial infection with vancomycin-dependent enterococci. Emerg Infect Dis. 10:1277-1281.
  43. Tang, P., P. Ng, M. Lum, M. Skulnick, G. W. Small, D. E. Low, A. Sarabia, T. Mazzulli, K. Wong, A. E. Simor, and B. M. Willey. 2004. Use of the Vitek-1 and Vitek-2 systems for detection of constitutive and inducible macrolide resistance in Group B streptococci. J Clin Microbiol. 42:2282-2284.
  44. Trick, W. E., S. M. Paule, S. Cunningham, R. L. Cordell, M. Lankford, V. Stosor, S. L. Solomon, and L. R. Peterson. 2004. Detection of vancomycin-resistant enterococci before and after antimicrobial therapy: use of conventional culture and polymerase chain reaction. Clin Infect Dis. 38:780-6.
  45. Tveten, Y., A. Jenkins, A. Digranes, K. K. Melby, A. G. Allum, and B.-E. Kristiansen. 2004. Comparison of PCR detection of mecA with agar dilution and Etest for oxacillin susceptibility testing in clinical isolates of coagulase-negative staphylococci. Clin Microbiol Infect. 10:462-465.
  46. Van Enk, R. A. 2004. Susceptibility testing of drugs and organisms not in CLSI guidelines. Clin Microbiol Newsletter. 26:41-44
  47. Whitener, C., S. Y. Park, F. Browne, L. Parent, K. Julian, B. Bozdogan, P. Appelbaum, J. Chaitram, L. Weigel, J. Jernigan, L. McDougal, F. Tenover, and S. Fridkin. 2004. Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure. Clin Infect Dis. 38:1049-1055.
  48. Woods, C., A. Cheng, J. V. Fowler, M. Moorefield, J. Frederick, G. Sakoulas, V. Meka, F. Tenover, P. Zwadyk, and K. Wilson. 2004. Endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin. Clin Infect Dis. 38:1188-1191.
  49. Yoon, J., C. Urban, C. Terzian, N. Mariano, and J. J. Rahal. 2004. In vitro double and triple synergistic activities of polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 48:753-757.
  50. Yu, V. L., C. C. Chiou, C. Feldman, A. Ortqvist, J. Rello, A. J. Morris, L. M. Baddour, C. M. Luna, D. R. Snydman, M. Ip, W. C. Ko, M. B. Chedid, A. Andremont, and K. P. Klugman. 2003. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis. 37:230-7.

    The following journals were reviewed to identify recent articles that may be of interest to those involved with antimicrobial susceptibility testing in a clinical microbiology laboratory:
    Date of Review: 7/31/04; previous posting 3/1/04

    Antimicrobial Agents and Chemotherapy
    Clinical Infectious Diseases
    Clinical Microbiology and Infection
    Clinical Microbiology Newsletter
    Clinical Microbiology Reviews
    Diagnostic Microbiology and Infectious Diseases
    Emerging Infectious Diseases
    European Journal of Clinical Microbiology and Infectious Diseases
    International Journal of Antimicrobial Agents
    Journal of Antimicrobial Chemotherapy


 
Contact Us:
  • Office of Surveillance, Epidemiology, and Laboratory Services
    1600 Clifton Road
    Mailstop E-94
    Atlanta, GA 30333, USA
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
    24 Hours/Every Day
  • OSELS@cdc.gov
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #